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Abstract
Purpose of Review In the context of human developmental
conditions, we review the conceptualisation of schizophrenia
as a neurodevelopmental disorder, the status of craniofacial
dysmorphology as a clinically accessible index of brain
dysmorphogenesis, the ability of genetically modified mouse
models of craniofacial dysmorphology to inform on the un-
derlying dysmorphogenic process and how geometric mor-
phometric techniques in mutant mice can extend quantitative
analysis.
Recent Findings Mutant mice with disruption of neuregulin-
1, a gene associated meta-analytically with risk for schizo-
phrenia, constitute proof-of-concept studies of murine facial
dysmorphology in a manner analogous to clinical studies in
schizophrenia. Geometric morphometric techniques informed
on the topography of facial dysmorphology and identified
asymmetry therein.
Summary Targeted disruption in mice of genes involved in
individual components of developmental processes and
analysis of resultant facial dysmorphology using geometric
morphome t r i c s c an i n fo rm on mechan i sms o f
dysmorphogenesis at levels of incisiveness not possible in
human subjects.
Keywords Neurodevelopmental disorders . Craniofacial
dysmorphology . Schizophrenia .Mouse models . 3D facial
imaging . Geometric morphometrics . Asymmetry
Introduction
Neurodevelopmental disorders comprise a wide spectrum of
human conditions having their origins in disruption to early
brain development that can be caused by a variety of genetic
abnormalities or environmental adversities. For some, such as
trisomy 21 (Down syndrome), 22q11.2 deletion syndrome
(velo-cardio-facial syndrome) and foetal alcohol syndrome,
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their designation reflects a known genetic or environmental
cause that indicates a route to investigating the underlying
pathobiological process(es). For others, there can be a
prolonged process of recognising their sometimes more subtle
neurodevelopmental origins before such investigations can
begin [1–4].
One of the most consistent anatomical phenotypes of
neurodevelopmental disorders is the presence of some form
of craniofacial dysmorphology. This relationship, long appre-
ciated and varying from subtle to severe [5, 6], is the inevitable
consequence of perturbation to the embryological unity and
molecular and physical interplay by which the brain and face
develop over early foetal life [7, 8••]. When sufficiently prom-
inent, such dysmorphology can be recognised and categorised
qualitatively by inspection, as practiced in clinical genetics
and paediatrics, and in the modern era, this is often a prelude
to molecular genetic investigation [9]. When less prominent,
such dysmorphology can be quantified and graded using tra-
ditional anthropometric techniques, i.e. measurements involv-
ing standard anatomical landmarks identified on the facial
surface of the individual, either manually or via conventional
(2-dimensional) photography [10], that can then be subjected
to conventional statistical techniques.
However, contemporary approaches increasingly empha-
sise that craniofacial dysmorphology is best accessed and
quantified in its intrinsic 3-dimensional (3D) space. Firstly,
this involves 3D acquisition techniques that directly capture
the facial surface (i.e. photogrammetry, laser surface imaging)
or indirectly allow reconstruction of the facial surface from
sequential thin sections across the craniofacies [i.e. X-ray
computed tomography (CT), magnetic resonance imaging
(MRI)] [6, 11•, 12]. Secondly, such data require a statistical
approach, known as geometric morphometrics, that analyses
dysmorphology in terms of its size and shape [13]: at a non-
technical level, a soccer ball and a table tennis ball have a
similar shape but differ in size, while a soccer ball and a rugby
ball differ in shape but have a similar size; more technically,
“Form is the combination of size and shape of a geometric
object in an arbitrary orientation and location. Shape is what
remains of the geometry of such an object once you standard-
ize for size” [11•]. These geometric morphometric techniques
are applied to 3D images on to which the coordinates of tra-
ditional anatomical landmarks can be (a) marked manually,
(b) marked automatically, or (c) defined and located from
surface curvature [6, 12, 14]; visualisation of the resultant
statistical models then reveals their biological import.
Such techniques have been applied to study normal human
craniofacial development and dysmorphology not only in
recognised neurodevelopmental and other craniofacial disor-
ders [6, 8••, 11•, 15••] but also in normal animals and in
putative animal models of human disorders. These typically
involve the application of geometric morphometrics to 3D
images of the rodent skull and related bony structures,
commonly obtained using micro-CT or MRI, on to which
traditional anatomical landmarks are applied; this literature is
not the topic of the present report and has been reviewed
extensively elsewhere [11•, 16–18]. In contrast, very few stud-
ies in animal have applied geometric morphometrics to the 3D
facial surface which, in contrast to the skull and related bony
structures, enjoys the closest embryological intimacy with the
brain [7, 8••], in a manner similar to studies in human subjects;
in instances where 3D images of facial shape have been ob-
tained in animal models as well as clinically, for example in
foetal alcohol syndrome [19], dysmorphology was not
analysed using geometric morphometrics. The challenges are
accentuated in mice, which are most commonly utilised for
gene deletion/transgenic mutation so as to target individual
biological mechanisms and create models informative on hu-
man genetic disorders.
In this review, we use schizophrenia to illustrate a process
of investigation from identification of this illness as a
neurodevelopmental disorder characterised by facial
dysmorphology, through insights into its genetic origins, to
3D imaging and geometric morphometrics in mice with dis-
ruption to a gene associated with risk for schizophrenia, in a
manner analogous to clinical studies. There are numerous mu-
tant mouse models related to schizophrenia [20], which have
generated an extensive phenotypic database at the levels of
behaviour, neurophysiology and brain anatomy. However, fa-
cial (as distinct from cranial) dysmorphology in such mouse
models has received scant attention due to challenges in ac-
quiring 3D images of the murine facial surface, applying a
comprehensive set of landmarks onto those surfaces, and the
optimal geometric morphometric approach to analysis thereof.
Yet, such investigations in a mutant mouse model would con-
stitute a heuristic for relating facial dysmorphology (the most
readily accessible index of brain dysmorphogenesis in human
subjects) to abnormal brain structure and function in a manner
that is difficult to realise in human subjects. We here describe
procedures for conducting such studies and outline initial ex-
ploratory findings.
Schizophrenia: a Neurodevelopmental Disorder
with Facial Dysmorphology
Over recent decades, epidemiological evidence and similarly
indirect (“soft”) biological findings indicate that schizophre-
nia is a disorder of subtle neurodevelopmental abnormality [2,
21–23]. However, even the most sophisticated of modern
structural and functional neuroimaging techniques applied to
young adults with psychotic illness, or even to adolescents
showing the putative “at risk mental state”/“attenuated psy-
chosis syndrome”, are unable to resolve hallmarks of abnor-
mal brain development [24, 25]. The need is for a “hard”
index of brain dysmorphogenesis during embryonic and foetal
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life that can be accessed readily in individuals throughout their
lifespan.
Congenital anomalies are major malformations that occur
to excess in multiple neurodevelopmental disorders, including
schizophrenia where their presence is associated prospectively
with a doubling of risk for the disorder [26]. Minor physical
anomalies (MPAs), including dermatoglyphic and capillary
nailfold plexus abnormalities, are more subtle anatomical
malformations involving regions of the body that share the
ectodermal origins of the brain. However, like congenital
a n oma l i e s , t h e y o c c u r t o e x c e s s i n mu l t i p l e
neurodevelopmental disorders; hence, their over-
representation in schizophrenia [2, 27–31] constitutes a non-
specific, qualitative indicator of dysmorphogenesis.
On this basis, we first used anthropometrics to quantify
facial dysmorphology in schizophrenia [32], an initiative that
continues [33]. Subsequently, we used a subset of linear mea-
sures to reconstruct the unique 3D configuration underlying a
set of landmarks and applied geometric morphometrics to (a)
identify an overall difference in facial shape, but not in size,
between schizophrenia cases and controls and (b) resolve in
schizophrenia a preliminary 3D topography of subtle,
frontonasal craniofacial dysmorphology and asymmetry
[34].We then introduced 3D laser surface imaging technology
and automatic application of semi-landmarks over the whole
facial surface [35, 36], to resolve the subtle facial
dysmorphology of schizophrenia [37] and extended these
studies to determine the extent to which facial dysmorphology
in schizophrenia is similar to or different from that evident in
bipolar disorder [38] and 22q11.2 deletion syndrome [15••], a
condition that carries a 25-fold increase in risk for
schizophrenia-like psychosis [39].
Schizophrenia: Exploring Facial Dysmorphology
in Mutant Mouse Models
Classical twin and family studies indicate that approximately
70–80% of variation in risk for schizophrenia can be ex-
plained by genes, with the number of individual genes asso-
ciated with that risk continuing to increase [40, 41•].
Neuregulin-1 (NRG1) is a broad family of epidermal growth
factors that are associated with various neurodevelopmental
and plasticity-related processes [42]. The NRG1 gene has
been associated replicably with risk for psychotic illness and
with structural and functional neuroimaging abnormalities in
psychosis [40, 43, 44]. Thus, members of the NRG1 gene
family have beenmodified inmutant mice to result in a variety
of psychosis-related phenotypes [43, 45, 46].
In the work to be outlined here, under approval from the
Research Ethics Committee of the Royal College of Surgeons
in Ireland, mice with heterozygous deletion of the trans-
membrane domain of NRG1 [47] constitute an exemplar for
proof-of-concept studies of murine facial dysmorphology in a
manner analogous to clinical studies in schizophrenia [37, 48],
bipolar disorder [38] and 22q11.2 deletion syndrome [15••].
Magnetic Resonance Imaging
As described previously [47], eight female NRG1 mutant and
eight genetically normal (wild-type, WT) mice were
anaesthetised and subjected to MRI at 7 Tesla (Bruker
Avance Biospec 70/30 USR, Karlsruhe, Germany). Under an-
aesthesia, mice were set in a standard position by placing the
upper incisors over a conventional “bite bar” and an arm light-
ly over the dorsal snout; NRG1 mutant and WT mice were
imaged alternatively. Two sets of scans were acquired consec-
utively, during the same session, with settings designed to best
capture the brain and craniofacies, respectively: (a) brain: po-
sitioned perpendicular to a line connecting the superior end of
the olfactory bulb with the superior end of the cerebellum; (b)
face: positioned perpendicular to a line connecting the anterior
tip of the pinna with the tip of the nose. Three mutually or-
thogonal (coronal, axial and sagittal) pilot images were used
for anatomical orientation of 54 coronal rapid-acquisition re-
laxation-enhancement images (TR = 6300 ms, TEeff = 36 ms,
RARE factor 8), eight averages (13 min and 26 s total scan
time) and field of view 18 mm (matrix 128 × 128 × 54, reso-
lution 0.141 × 0.141 × 0.3 mm3). At the end of the experiment,
mice were euthanized using an overdose of anaesthetic.
Anatomical Landmarks and Geometrically Homologous
Semi-Landmarks
MRI-derived 3D facial surfaces were reconstructed from cor-
onal MR images using Mimics 9.1 software (Materialise,
Leuven, Belgium). Facial shape was characterised first by
identifying manually the coordinates of ten biologically ho-
mologous anatomical landmarks (s1–10) analogous to those
used traditionally in humans: four on the midline and six as
left (L) and right (R) counterparts of each of three lateralised
points, as illustrated in Fig. 1. These type 2 landmarks, i.e.
extremes of curvature (saddle-like points, tip-like points)
characterising a single location [12, 15••], were defined as
follows:
[s1] pronasale: most anterior midpoint of the nasal tip, as
tip-like point in cap/peak region; [s2/s3, L/R] alar curvature
point: point located at the facial insertion of each alar base;
following saddle-ridge starting at pronasale and continuing to
saddle-like point in saddle-ridge region; [s4/s5, L/R] porion:
highest point on the upper margin of the cutaneous auditory
meatus; as deepest point on the front part of the ear lobe,
middle point of the entrance to external acoustic meatus and
deepest point in a cup/pit region; [s6] gnathion: most inferior
midpoint on the soft tissue contour of the chin; tip-like point in
cap/peak region; [s7/s8, L/R] cheilion, L/R: point located at
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each labial commissure; saddle-like point in saddle-ridge re-
gion; [s9] sublabiale: most posterior midpoint on the
labiomental soft tissue contour that defines the border between
the lower lip and the chin; as deepest point in the region
between gnathion and labiale inferius; deepest point in cup/
pit region; [s10] labiale inferius: midpoint of the vermilion
line of the lower lip; as most inferior midpoint on the soft
tissue contour of the lower lip; tip-like point in cap/peak
region.
From these ten landmarks, 170 geometrically homologous
semi-landmarks were positioned along 12 anatomical curves
(c1–12), as L/R counterparts of each of six lateralised curves,
and across two intervening surface patches [12, 15••];
as illustrated in Fig. 1, this gave a rich characterisation of the
craniofacial surface, to include regions where traditional land-
marks are not present. Curves can be divided to two types
[12, 15••]: (a) valley curves, i.e. a curve following the deepest
path in a valley, as defined by points with strongest local
positive curvature; (b) ridge curves, i.e. a curve following
the ridge, defined by points with strongest local negative
curvature:
L/R outer diastemal curve (c1/c2) (ridge curve); L/R outer
diastemal curve (c3/c4) (valley curve); L/R dentary curve (c5/
c6) (valley curve); L/R zygomatic curve (c7/c8) (valley
curve); L/R inferior-ear curve (c9/c10) (valley curve); L/R
posterior-ear curve (c11/c12) (valley curve). In Fig. 1, (c9/
c10) and (c11/c12) in effect jointly create one continuous val-
ley that is rendered visible as an ear curve (c9/c10) (valley
curve); p1/p2 is a closed surface patch between four curves
(c1/c2, c7/c8) and three landmarks (s1–3) that are used for
warping purposes in the course of geometric morphometric
analysis (see succeeding texts).
Semi-landmarks were initially positioned on anatomical
curves and intervening surface patches in an equidistant man-
ner. The semi-landmarks were subsequently repositioned by
sliding across the curves and surfaces, using the minimisation
of bending energy (BE) [12, 15••] as a criterion, to create
geometrically homologous points with respect to a
symmetrised reference shape. The equidistant resampling
and sliding of semi-landmarks and subsequent statistical anal-
yses were performed in R software system [49].
Geometric Morphometrics and Visualisation
Firstly, one particular facial image was chosen as a reference
shape, symmetrised, to create a template for visualisation.
Secondly, Generalised Procrustes Analysis (GPA) [13] was
performed to remove effects of location, scale and orientation
and to calculate the Procrustes mean shape. This was then
symmetrised, to provide a new reference shape, and sliding
was repeated using this reference. These two steps, GPA and
sliding, were repeated iteratively until convergence (in total,
five iteration steps). For final registration of the images, shape
coordinates were calculated by GPA.
For visualisation, all surface points were estimated by in-
terpolating thin-plate spline (TPS) based on 180 landmarks
and semi-landmarks, using the first craniofacial triangulated
surface as reference. To test overall group differences, a per-
mutation Goodall F-test (999 permutations) [13, 15••] was
used; p values were calculated for the entire semi-landmark
set, each curve and surface patch separately. For visualisation,
F-statistics were calculated point-wise and displayed as
coloured surface maps (statistical parametric map, SPM)
based on 27,490 point locations. To explore the nature of
Fig. 1 3D design of
(semi)landmarks, with anatomical
landmarks (lndms), bilateral
curves (c1–10; c11/c12 are so
adjacent to c9/c10 as to preclude
independent visualisation) and
patches (p1/p2) on Procrustes
mean mouse facial surface (the
mean of Procrustes coordinates of
all 16 cases and 16 relabelled
reflected cases), for each of four
views: top left, coronal; top right,
sagittal; bottom left, dorsal;
bottom right, ventral. In
accordance with radiological
convention, the left side of the
specimen is shown on the right of
the image for each view
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difference between the groups, the linear discriminant analysis
(LDA) was used. The results of LDA (in LD1 subspace; since
there are only two groups, WT and NRG1, there is only LD1)
were visualised by SPMs of 27,490 point-wise Procrustes
shape distances (PSDs) calculated between two extreme
shapes estimated in the LD1 subspace.
Asymmetry was quantified by comparing the landmarks and
semi-landmarks with reflected and relabelled (RR) versions con-
structed with respect to the mid-sagittal plane. Firstly, this plane
was estimated from four unpaired mid-sagittal landmarks (s1,
s6, s9 and s10) by ordinary least squares and rotated to corre-
spond to the (x,y) plane. Secondly, the sign and labels of paired
landmarks and semi-landmarks were reversed across L and R
sides of the craniofacial surface. The original Procrustes shape
coordinates (PSC), together with their RR counterparts, were
jointly submitted to GPA to register both into the same shape
space. Fluctuating asymmetry (FA) expresses how the difference
between the original and RR shapes fluctuates in the sample;
this is calculated as the sum of squares of individual asymmetry
scores, i.e. Procrustes distances between original and RR PSC of
each shape. The asymmetry of the means (AM) is calculated as
the sum of squares of Procrustes distances between the original
and RR Procrustes mean shape and, when multiplied by sample
size, is called directional asymmetry (DA).
To test DA, we used a permutation Mardia-Bookstein F-test
(999 permutations) [15••, 50]. Probability (p) values were cal-
culated for the complete semi-landmark set, each curve and
surface patch separately. All permutation two-sample t-tests
(999 permutations) for mean difference were performed in the
Procrustes shape space of both WT and NRG1 mutants, and
also in separate subspaces of WT and NRG1 mutants. To test
AM and DA, PSD and BE approaches can be used; both are
independent of shape orientation but dependent on mean shape
choice. To explore the nature of differences in asymmetry be-
tween the groups, we again used LDA in LD1 subspace,
visualised by SPMs of 27,490 PSDs calculated between two
extreme shapes estimated in LD1 subspace of asymmetry.
Facial Dysmorphology in NRG1Mutant vsWTMice
Overview
In initial exploratory analyses, while overall shape did not
differ between NRG1 mutants and WT across the whole
semi-landmark set (Goodall F-test, p = 0.4), there were mar-
ginal differences for the dentary curves (c5/c6, p = 0.07) and
the outer diastemal curves (c3/c4, p = 0.09) but not for other
curves or surface patches (p > 0.2).
Facial Dysmorphology
Figure 2 shows a SPM for comparisons between NRG1 and
WT across the 27,490 point locations on the facial surface; in
accordance with radiological convention, the left sides of the
specimen are shown on the right of the images as viewed. The
Fig. 2 Statistical parametric maps of F-statistics for differences between
NRG1 andWTacross the 27,490 point locations on the facial surface, for
each of four views: top left, coronal; top right, sagittal; bottom left, dorsal;
bottom right, ventral. The scale indicates values of F-statistics, with
values of 1.743 and above indicating significance at p ≤ 0.05. In
accordance with radiological convention, the left side of the specimen is
shown on the right of the image for each view
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scale in Fig. 2 indicates values of F-statistics, with values of
1.743 and above indicating significance at significance level
p = 0.05 (based on F-distribution with 14 and 196 degrees of
freedom; see [50]): differences between NRG1 and WTwere
most evident (i.e. orange to pink-grey) for the left anterior-
dorsal/ventral maxillary and left posterior-ventral regions of
the snout, the right anterior-ventral maxillary region of the
snout and a right posterior-dorsal periauricular region; the an-
terior mandibular and other regions of the snout and head (i.e.
green) did not differ systematically between NRG1 and WT.
Asymmetry
Directional asymmetry (the same as AMat a significance level
p = 0.05) was present in both WT (whole semi-landmark set,
p < 0.001) and NRG1 mutants (whole semi-landmark set,
p < 0.001). Overall, the evidence for differences in DA be-
tween NRG1 mutants and WT across the whole semi-
landmark set (p = 0.1) is not convincing, but there were sig-
nificant differences for the inferior ear curve (c9 vs c10,
p = 0.04) and marginally for the posterior ear curve (c11 vs
c12, p = 0.06). The overall mean asymmetry ratio (FAPSD
NRG1/WT) was 1.76, indicating greater asymmetry in the
NRG1 group; FAPSD was highest for the inferior ear curve
(c9/c10, FAPSD = 3.22) and the posterior ear curve (c11/c12,
FAPSD = 2.04), i.e. the curves showing the most statistically
robust differences in DA between NRG1 mutants and WT.
Figure 3 shows plain surfaces for extreme NRG1 shape and
extreme WT shape of LDA of differences in asymmetry in
LD1 subspace; in accordance with radiological convention,




In this report, we consider (a) the recognition and study of
facial dysmorphology in schizophrenia as an externally acces-
sible index of brain dysmorphogenesis that can be more easily
evaluated in clinical populations than can the brain itself and
(b) the quantitative assessment of craniofacial dysmorphology
in a genetically modified (and, by extension, in any early
adversity-determined) mouse model of schizophrenia in a
manner analogous to clinical studies of 3D facial
dysmorphology in schizophrenia and its 22q11.2DS human
genetic model [15••, 37, 38].
Facial and Brain Dysmorphogenesis
Mice with disruption of NRG1, a gene associated meta-
analytically with risk for schizophrenia [40, 44], were
studied on a proof-of-concept basis. As expected, geomet-
ric morphometric analysis revealed no systematic facial
dysmorphology in NRG1 mutants at a global level.
However, at a local level, there is some evidence for
dysmorphology in the left anterior-dorsal/ventral maxil-
lary and left posterior-ventral regions of the snout, the
right anterior-ventral maxillary region of the snout, and
a right posterior-dorsal periauricular region. The anterior
Fig. 3 3D visualisation as plain surfaces for (top row) extremeWTshape
and (bottom row) extreme NRG1 shape of LDA of differences in
asymmetry in LD1 subspace (after arbitrary magnification) for each of
four views: left, coronal; centre-left, sagittal; centre-right, dorsal; right,
ventral. In accordance with radiological convention, the left side of the
specimen is shown on the right of the image for each view
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mandibular and other regions of the snout and head were
largely unaffected. It is unreasonable to expect any simple
concordance between the topographies of facial
dysmorphology in schizophrenia patients and in mice with
disruption of a single risk gene among the large number
of genes associated with risk for the disorder [40, 41•,
44]; the greater import is a research paradigm and analyt-
ical approach that is capable of resolving a topography of
facial dysmorphology in mice with disruption of a given
risk gene for schizophrenia and can be generalised across
neurodevelopmental and other craniofacial disorders.
The complex cellular processes that underlie the embryo-
logical unity and molecular and physical interplay by which
the face and brain develop over early foetal life are increas-
ingly understood and appear to generalise across mammalian
species but are beyond the scope of the present report (see
[8••, 11•]). Craniofacial anomalies can largely be traced to
abnormalities in the formation, migration and differentiation
of neural crest cells [8••, 51]. That NRG1 and its erbB4 recep-
tor have been shown to play an important role in the develop-
ment of ectodermal/neural tissue, including mouse
craniofacies [42, 52, 53], suggests a putative basis for the
facial phenotype of NRG1 mutant mice.
Facial and Brain Asymmetry
A notable feature is the presence of asymmetry in mouse facial
morphology and its disruption in NRG1 mutants. Asymmetry
is an intrinsic feature of the human face that influences normal
human behaviours such as perception of attractiveness and is
disrupted in neurodevelopmental conditions such as autism
spectrum disorder [54–56]; similarly, the normal human brain
is asymmetric in a manner that may be disrupted in schizophre-
nia [57, 58•]. Asymmetry in the mouse craniofacies [59] and
brain [60] is also recognised. While craniofacial asymmetry in
mice can be altered by foetal exposure to alcohol or other
dysmorphogens, this is typically assessed using geometric mor-
phometrics of skeletal landmarks, linear distances, or qualita-
tive evaluation of the facial surface [19, 61]. Geometric mor-
phometric analysis of the facial surface indicated that while
both NRG1 mutant and WT mice showed facial asymmetry,
this was accentuated in NRG1 mutants.
The complex cellular processes that underlie the develop-
ment of asymmetry are also increasingly understood and ap-
pear to generalise across mammalian species, but they are
again beyond the scope of the present report (see [62, 63]).
Among these, nodal, an evolutionarily conserved member of
the transforming growth factor-β (TGF-β) superfamily of se-
creted signalling factors, plays a key role in embryonic devel-
opment and asymmetry [64–66]. That NRG1 and TGF-β sig-
nalling cascades appear to overlap in promoting cellular dif-
ferentiation and migration [67] suggests a putative basis for
the asymmetric facial phenotype of NRG1 mutant mice.
Conclusions and Future Directions
In the context of a panoply of human developmental conditions,
the studies reviewed here indicate the following: (a) the concep-
tualisation of schizophrenia and related psychotic illness as
neurodevelopmental disorders; (b) the status of craniofacial
dysmorphology as a clinically accessible index of brain
dysmorphogenesis; (c) the ability of genetically modified mouse
models of craniofacial dysmorphology to inform on the under-
lying dysmorphogenic process; (d) how geometric morphomet-
ric techniques in mutant mice can extend quantitative analysis of
dysmorphology from the skull and related bony structures to the
ectodermally derived facial surface that enjoys the greatest em-
bryological intimacy with the brain; and (e) how targeted dis-
ruption in mice of genes involved in individual components of
the dysmorphogenic process can inform on pathobiology at
levels of incisiveness not possible in human subjects.
Going forward, studies in mutant (and, indeed, in any early
adversity-determined) mouse models should recognise and
confront a number of challenges: Firstly, facial shape is well-
recognised to differ between men and women, with aspects of
dysmorphology in human developmental disorders differing
between male and female subjects [6, 55]; hence, studies in
mice should involve systematic comparisons between the
sexes. Secondly, human facial dysmorphology can be potential-
ly modified by factors unrelated to dysmorphogenesis, such as
disease-related weight loss or drug treatments associated with
weight gain [37, 38]; hence, studies in mice should clarify any
influence of these factors. Thirdly, evolving understanding of
(a) genetic regulation both of normal craniofacial morphology
and of risk for human neurodevelopmental disorders and (b)
gene expression domains in distinct fields of craniofacial devel-
opment [7, 8••, 11•] behoves investigators to exploit the full
potential of these insights in future mouse models.
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